119 related articles for article (PubMed ID: 34247376)
21. Olmsted syndrome: report of a case with study of the cellular proliferation in keratoderma.
Requena L; Manzarbeitia F; Moreno C; Izquierdo MJ; Pastor MA; Carrasco L; Fariña MC; Martín L
Am J Dermatopathol; 2001 Dec; 23(6):514-20. PubMed ID: 11801792
[TBL] [Abstract][Full Text] [Related]
22. Palmoplantar keratoderma and perioral keratotic plaques with hypotrichosis in a child.
Zhang LW; Wang WJ; Chen T; Fu LX; Lu YH
Pediatr Dermatol; 2019 Nov; 36(6):942-943. PubMed ID: 31778560
[No Abstract] [Full Text] [Related]
23. Olmsted syndrome: report of two new cases and literature review.
Larrègue M; Callot V; Kanitakis J; Suau AM; Foret M
J Dermatol; 2000 Sep; 27(9):557-68. PubMed ID: 11052230
[TBL] [Abstract][Full Text] [Related]
24. Two for two: Dual therapy with erlotinib and acitretin for twins with severe keratoderma in Olmsted syndrome.
Butala S; Phan S; Siegel DH; Carlberg V; Paller AS
Pediatr Dermatol; 2023; 40(4):735-737. PubMed ID: 36709954
[TBL] [Abstract][Full Text] [Related]
25. Olmsted syndrome with squamous cell carcinoma of extremities and adenocarcinoma of the lung: failure to detect loricrin gene mutation.
Ogawa F; Udono M; Murota H; Shimizu K; Takahashi H; Ishida-Yamamoto A; Iizuka H; Katayama I
Eur J Dermatol; 2003; 13(6):524-8. PubMed ID: 14721769
[TBL] [Abstract][Full Text] [Related]
26. Decreases in 15-lipoxygenase metabolites in Olmsted syndrome model rats.
Wakabayashi M; Yoshioka T; Higashino K; Numata Y; Igarashi Y; Kihara A
J Dermatol Sci; 2017 Mar; 85(3):186-196. PubMed ID: 28024685
[TBL] [Abstract][Full Text] [Related]
27. Exome sequencing reveals mutation in GJA1 as a cause of keratoderma-hypotrichosis-leukonychia totalis syndrome.
Wang H; Cao X; Lin Z; Lee M; Jia X; Ren Y; Dai L; Guan L; Zhang J; Lin X; Zhang J; Chen Q; Feng C; Zhou EY; Yin J; Xu G; Yang Y
Hum Mol Genet; 2015 Jan; 24(1):243-50. PubMed ID: 25168385
[TBL] [Abstract][Full Text] [Related]
28. Olmsted syndrome causing point mutants of TRPV3 (G568C and G568D) show defects in intracellular Ca
Jain A; Sahu RP; Goswami C
Biochem Biophys Res Commun; 2022 Nov; 628():32-39. PubMed ID: 36063600
[TBL] [Abstract][Full Text] [Related]
29. [Familial palmo-plantar keratoderma with epidermolytic hyperkeratosis (author's transl)].
Moulin G; Bouchet R
Ann Dermatol Venereol; 1977 Jan; 104(1):38-44. PubMed ID: 14586
[TBL] [Abstract][Full Text] [Related]
30. Mal de Meleda: a report of two cases of familial occurrence.
Morais e Silva FA; Cunha TV; Boeno Edos S; Steiner D
An Bras Dermatol; 2011; 86(4 Suppl 1):S100-3. PubMed ID: 22068784
[TBL] [Abstract][Full Text] [Related]
31. Olmsted syndrome: clinical, molecular and therapeutic aspects.
Duchatelet S; Hovnanian A
Orphanet J Rare Dis; 2015 Mar; 10():33. PubMed ID: 25886873
[TBL] [Abstract][Full Text] [Related]
32. Alopecia, palmoplantar keratoderma, skin fragility and follicular hyperkeratoses due to compound heterozygous mutations in desmoplakin.
Tekin B; Yucelten D; Liu L; McGrath JA
Australas J Dermatol; 2017 Feb; 58(1):e17-e19. PubMed ID: 26303123
[TBL] [Abstract][Full Text] [Related]
33. Mutation in TRPV3 causes painful focal plantar keratoderma.
Peters F; Kopp J; Fischer J; Tantcheva-Poór I
J Eur Acad Dermatol Venereol; 2020 Oct; 34(10):e620-e622. PubMed ID: 32314439
[No Abstract] [Full Text] [Related]
34. Targeted Inhibition of the Epidermal Growth Factor Receptor and Mammalian Target of Rapamycin Signaling Pathways in Olmsted Syndrome.
Zhang A; Duchatelet S; Lakdawala N; Tower RL; Diamond C; Marathe K; Hill I; Richard G; Diab Y; Kirkorian AY; Watanabe F; Siegel DH; Hovnanian A
JAMA Dermatol; 2020 Feb; 156(2):196-200. PubMed ID: 31895414
[TBL] [Abstract][Full Text] [Related]
35. Ultrastructural changes resulting from keratin-9 gene mutations in two families with epidermolytic palmoplantar keratoderma.
Navsaria HA; Swensson O; Ratnavel RC; Shamsher M; McLean WH; Lane EB; Griffiths D; Eady RA; Leigh IM
J Invest Dermatol; 1995 Mar; 104(3):425-9. PubMed ID: 7532198
[TBL] [Abstract][Full Text] [Related]
36. Focal palmoplantar and gingival hyperkeratosis: a case report.
Seehra J; Thakker N; Duxbury AJ; Sloan P; Ariyaratnam S
Dent Update; 2007 Jun; 34(5):290-2, 294. PubMed ID: 17624145
[TBL] [Abstract][Full Text] [Related]
37. Understanding the phenotypic similarities between IFAP and Olmsted syndrome from a molecular perspective: the interaction of MBTPS2 and TRPV3.
Nemer G; Safi R; Kreidieh F; Usta J; Bergqvist C; Ballout F; Btadini W; Hamzeh N; Abbas O; Kibbi AG; Shimomura Y; Kurban M
Arch Dermatol Res; 2017 Oct; 309(8):637-643. PubMed ID: 28717930
[TBL] [Abstract][Full Text] [Related]
38. [Focal palmoplantar and oral mucosa hyperkeratosis syndrome].
Bethke G; Kolde G; Bethke G; Reichart PA
Mund Kiefer Gesichtschir; 2001 May; 5(3):202-5. PubMed ID: 11432338
[TBL] [Abstract][Full Text] [Related]
39. Epidermolytic hyperkeratosis with palmoplantar keratoderma in a patient with KRT10 mutation.
Morais P; Mota A; Baudrier T; Lopes JM; Cerqueira R; Tavares P; Azevedo F
Eur J Dermatol; 2009; 19(4):333-6. PubMed ID: 19443303
[TBL] [Abstract][Full Text] [Related]
40. Olmsted syndrome-palmoplantar and periorificial keratodermas: association with malignant melanoma.
Dessureault J; Poulin Y; Bourcier M; Gagne E
J Cutan Med Surg; 2003; 7(3):236-42. PubMed ID: 12704531
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
